Mainz Biomed N.V. (MYNZ) SEC Filings — 2024
16 SEC filings for Mainz Biomed N.V. (MYNZ) in 2024.
Filings
- Mainz Biomed Sells Units to Institutional Investor — 6-K · Dec 16, 2024
- Mainz Biomed Prices $8M Follow-On Offering — 6-K · Dec 13, 2024
- Mainz Biomed Announces Stock Split — 6-K · Nov 29, 2024
- Mainz Biomed Shareholders Approve All Proposals at EGM — 6-K · Nov 15, 2024
- Mainz Biomed Partners with Thermo Fisher for Cancer Test Development — 6-K · Nov 12, 2024
- Mainz Biomed Files 6-K with October Press Release — 6-K · Oct 21, 2024
- Mainz Biomed N.V. Files Q2 2024 Financial Update — 6-K · Oct 18, 2024
- Mainz Biomed Amends Yorkville Pre-Paid Advance Agreement — 6-K · Oct 9, 2024
- Mainz Biomed N.V. SC 13G/A Filing — SC 13G/A · Oct 7, 2024
- Mainz Biomed N.V. Convertible Note Terms Revealed — 6-K · Oct 3, 2024
- Mainz Biomed Shareholders Approve All Proposals at AGM — 6-K · May 31, 2024
- Mainz Biomed Schedules Annual Shareholder Meeting for May 31 — 6-K · Apr 24, 2024
- Mainz Biomed Reports on Yorkville Financing Agreement — 6-K · Apr 19, 2024
- Mainz Biomed N.V. Files 20-F Annual Report for Fiscal Year Ended December 31, 2023 — 20-F · Apr 9, 2024
- Mainz Biomed Reports Leadership Changes and Carve-Out Adoption — 6-K · Feb 23, 2024
- Mainz Biomed N.V. SC 13G/A Filing — SC 13G/A · Feb 13, 2024